secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001295947-25-000027
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Q1 revenue down 6.6%, misses; acquires Pillar5 for CAD 150M, cuts FY26 outlook
--------------------------------------------------------------------------------

- Revenue $249.5M (-6.6% YoY); diluted EPS $0.95 ($0.90 adjusted).
- Clear Eyes supply constraints drove North American OTC revenue down to $212.6M.
- Acquiring Pillar5 Pharma for CAD 150M cash; expected to close Q3 FY2026.
- FY2026 outlook cut: revenue now $1.10-1.115B, EPS $4.50-4.58 (from $4.70-4.82).
- Net debt ~$0.9B; leverage 2.4x; free cash flow guidance unchanged at $245M+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594725000027/0001295947-25-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594725000027/pbh-20250807.htm
  HTML page:      https://secwatch.observer/filing/0001295947-25-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer